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Synthesis of 1,2,3,4,6-penta-O-acetyl-α/β-D-mannopyranose (M2).
1,2,3,4,6-penta-O-acetyl-α/β-D-mannopyranose was prepared according to the procedure reported by Jakeman. [2] D-Mannose (10.00 g, 55.6 mmol, M1), pyridine (45 mL), and acetic anhydride (52 mL, 556 mmol) were combined in a 250 ml flask and stirred at room temperature.
The mannose was dissolved gradually. After stirring for 4 h, the reaction mixture was diluted with ice-water (100 mL) and extracted with DCM (100 mL) three times. -5 - 
Synthesis of 2'-azidoethyl 2,3,4,6-tetra-O-acetyl-α-D-manno-pyranoside (M4

Synthesis of 2'-azidoethyl-O-α-D-mannopyranoside (M5
Synthesis of 5-[4-(prop-2-yn-1-yloxy)benzyl]-1,3-dioxolane-2,4-dione (Tyr(alkynyl)-OCA).
Tyr(alkynyl)-OCA was synthesized as described previously. [3, 4] 
Synthesis of poly(Lac
Preparation of micelles and determination of critical micelle concentration (CMC).
PLA 30 -b-(PTA 10 -g-mannose) (10.0 mg) was dissolved in DMF (2 mL) and DI water (20 mL) was slowly added under vigorous stirring. After vigorous stirring for another 2 h at room temperature, the micelles were obtained and further purified by ultrafiltration using Amicon Ultra-4 centrifugal filter unit (MWCO 3 kDa, 3500 rpm) to remove DMF and lyophilized. The CMC of
the micelle was determined using Nile Red (NR) as a fluorescence probe. [5] NR in THF (0.1 mg/mL, 10 µL) was added to a glass vial via a microsyringe. After THF was evaporated, a micellar solution (2 mL) was added. The concentration of the micellar solution varied from 5 × 10 -4 to 0.25 mg/mL. Then the solution was racked for more than 1 h. Finally, fluorescence spectra were recorded with the excitation wavelength at 557 nm.
Preparation of DOX-Loaded Micelles. DOX-loaded micelles were readily prepared using the cosolvent method. [6] Briefly, DOX·HCl (5.3 mg, 9.2 mmol) and 1.5-fold molar amount of triethylamine (TEA, 2 µL, 13.8 mmol) were dissolved in DMSO (5 mL) and stirred at room temperature for 2 h. [7] Subsequently, PLA 30 -b-(PTA 10 -g-mannose) (10.0 mg) were completely dissolved in DMF (1.5 mL) and then mixed with DOX solution (1 mL, 1 mg). DI water (20 mL) was added slowly by using a microsyringe under vigorous stirring. After being stirred for another 2 h, the solution was further purified by ultrafiltration using Amicon Ultra-4 centrifugal filter unit (MWCO 3 kDa, 3500 rpm) to remove DMF and free drug and the micelles were then lyophilized. To acquire sink conditions, in vitro drug release test was performed at low drug concentration. [8] Briefly, DOX-loaded freeze-dried micelles (5 mg) was dispersed in 3 mL was determined by spectrofluorimetry (Ex=485 nm, Em=590 nm), and the cumulative release (CR) was calculated as described previously. [9] Cell uptake. HepG-2 and A549 cells were seeded on 96-well plates at 1×10 4 MTT assay. The cytotoxicity of blank micelles, DOX-loaded micelles, and free DOX against HepG-2 and A549 cells was evaluated using the MTT assay. Cells were seeded on 96-well plates at 1×10 4 cells/well and cultured for 24 h before replacement of fresh media (100 μL/well).
DOX-loaded micelles and free DOX were added at the final concentration ranges of 0-100 μM DOX-equiv for free DOX and 0-250 μM DOX-equiv for DOX-micelles. Blank micelles were added at the same amount as their DOX-loaded analogues. Cells were further incubated for 72 h before viability assessment. The IC 50 values were expressed as concentration (μM) of DOX-equiv. 
